The Challenges Ahead for Eli Lilly
Interactive Video
•
Business, Engineering, Life Skills
•
University
•
Hard
Wayground Content
FREE Resource
Eli Lilly has improved its R&D success since 2010, launching several major drugs. However, they face increased market competition and pricing pressures from PBMs and insurers. Future strategies may include acquisitions and focusing on validated targets, but challenges remain, such as the Alzheimer's drug trials. Market expectations often exceed actual sales due to cost concerns, as seen with cholesterol drugs from Amgen and others.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What role do PBMs and insurance companies play in Eli Lilly's market strategy?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What risks does Eli Lilly encounter when launching new drugs, particularly for Alzheimer's?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
